{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T15:30:46Z","timestamp":1763479846388},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/wnf.0b013e31824687bf","type":"journal-article","created":{"date-parts":[[2012,2,8]],"date-time":"2012-02-08T12:28:23Z","timestamp":1328704103000},"page":"73-76","source":"Crossref","is-referenced-by-count":15,"title":["Pramipexole May Be an Effective Treatment Option in Essential Tremor"],"prefix":"10.1097","volume":"35","author":[{"given":"Mih\u00e1ly","family":"Herceg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferenc","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Endre","family":"P\u00e1l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3zsef","family":"Janszky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ildik\u00f3","family":"K\u00e9sm\u00e1rky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e1muel","family":"Komoly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"5","key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/mds.22838","article-title":"How common is the most common adult movement disorder Update on the worldwide prevalence of essential tremor.","volume":"25","author":"Louis","year":"2010","journal-title":"Mov Disord"},{"issue":"4","key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11910-009-0041-6","article-title":"An update on essential tremor.","volume":"9","author":"Elble","year":"2009","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1468-1331.2009.02926.x","article-title":"How are we doing with the treatment of essential tremor (ET): Persistence of patients with ET on medication: data from 528 patients in three settings.","volume":"17","author":"Louis","year":"2010","journal-title":"Eur J Neurol"},{"issue":"6","key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/WNF.0b013E31807A32C6","article-title":"Levetiracetam is not effective for essential tremor.","volume":"30","author":"Elble","year":"2007","journal-title":"Clin Neuropharmacol"},{"issue":"10","key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/mds.20147","article-title":"Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor.","volume":"19","author":"Handforth","year":"2004","journal-title":"Mov Disord"},{"issue":"suppl 3","key":"R15-4-20210203","first-page":"2","article-title":"Consensus statement of the Movement Disorder Society on Tremor, Ad Hoc Scientific Committee.","volume":"13","author":"Deuschl","year":"1998","journal-title":"Mov Disord"},{"issue":"34","key":"R19-4-20210203","first-page":"1667","article-title":"Health-related quality of life of the Hungarian population.","volume":"144","author":"Szende","year":"2003","journal-title":"Orv Hetil"},{"issue":"6","key":"R20-4-20210203","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s11136-004-7713-0","article-title":"Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.","volume":"14","author":"Walters","year":"2005","journal-title":"Qual Life Res"},{"issue":"1-2","key":"R22-4-20210203","first-page":"42","article-title":"The use of Stalevo in Hungary for patients with Parkinson disease and its effect on the quality of life.","volume":"61","author":"Klivenyi","year":"2008","journal-title":"Ideggyogy Sz"},{"issue":"14","key":"R24-4-20210203","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/mds.22755","article-title":"Essential tremorneurodegenerative or nondegenerative disease towards a working definition of ET.","volume":"24","author":"Deuschl","year":"2009","journal-title":"Mov Disord"},{"issue":"3","key":"R26-4-20210203","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/mds.23509","article-title":"Essential tremor and Parkinsons disease: lack of a link.","volume":"26","author":"Adler","year":"2011","journal-title":"Mov Disord"},{"issue":"10","key":"R27-4-20210203","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/mds.21383","article-title":"Prevalence of essential tremor in patients with Parkinsons disease vs. Parkinson-plus syndromes.","volume":"22","author":"Louis","year":"2007","journal-title":"Mov Disord"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0b013e31824687bf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:14:57Z","timestamp":1620976497000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201203000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e31824687bf","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}